GenMark Diagnostics Schedules Fourth Quarter and Full Year 2012 Financial Results and Conference Cal

Before you go, we thought you'd like these...
Before you go close icon

GenMark Diagnostics Schedules Fourth Quarter and Full Year 2012 Financial Results and Conference Call for March 12, 2013

CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NAS: GNMK) today announced that it plans to release its fourth quarter and full year 2012 earnings results after market close on Tuesday, March 12, 2013. Management will hold a conference call to review the Company's fourth quarter and full year 2012 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the GenMark Diagnostics, Inc. website at www.genmarkdx.com under the investor relations section and will be archived for future reference.

To listen to the conference call, please dial (877) 312-5847 (US/Canada) or (253) 237-1154 (International) and use the conference ID number "16992443" approximately five minutes prior to the start time.


About GenMark Diagnostics

GenMark Diagnostics is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark's proprietary eSensor® detection technology, GenMark's eSensor XT-8™ system is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. GenMark currently markets four tests that are FDA cleared for IVD use: Cystic Fibrosis Genotyping Test, Respiratory Viral Panel, Thrombophilia Risk Test, and Warfarin Sensitivity Test. A number of other tests, including HCV Genotyping, 2C19 Genotyping, and 3A4/3A5 Genotyping are in development. For more information, visit www.genmarkdx.com.



GenMark Diagnostics, Inc.
Hany Massarany
President/Chief Executive Officer
760-448-4358

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:

The article GenMark Diagnostics Schedules Fourth Quarter and Full Year 2012 Financial Results and Conference Call for March 12, 2013 originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners